
RNA-based medicines and treatment methods open up a new dimension in modern medicine. Despite their potential, RNA-based therapies are faced with major challenges: The instability of RNA and its rapid degradation in the body, combined with the necessity of ultra-cold storage or encapsulation, mean that innovative technological solutions are required in order to ensure efficacy and safety. This is where the Research Training Group “RNApp” comes in, with a total of twelve doctoral projects - among them the Fraunhofer Institute for Surface Engineering and Thin Films IST.
more info